DRMA
DRMA
NASDAQ · Biotechnology

Dermata Therapeutics Inc

$1.12
-0.02 (-1.75%)
As of Sep 28, 10:44 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,362.5% upside
Low Target $26.82
Average Target $38.78
High Target $44.92
Current Price $1.12
Current
$1.12
Target
$38.78
$26.82 $38.78 avg $44.92
Scenario Analysis
Bear Case
$26.82
2,294.6%
Low target
Base Case
$38.78
+3,362.5%
Avg target
Bull Case
$44.92
+3,910.7%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$5.87
-80.9% from high
52-Week Low
$0.95
+17.8% from low
Target vs 52W High
$38.78
+560.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%